The cutaneous lymphocyte-associated antigen recognized by the monoclonal antibody HECA-452 has been thought to playa major role in the homing of memory T-cell subsets to the skin by virtue of its ability to bind to E-selectin of dermal microvascular endothelial cells. Considering that the homing of different leukocyte populations to the skin may involve similar mechanisms, we studied the expression of HECA-452-reactive molecules on COla+ epidermal Langerhans cells. Immunofluorescence double-labeling of cryostat sections and epidermal sheets of normal skin revealed HECA-452 immunoreactivity on a subpopulation of dermal and epidermal COla+ cells, whereas upon flow-cytometric analysis of epidermal single cell suspensions virtually all CD1a+ cells bound HECA-452 antibodies. We observed a marked upregulation of HECA-452-antigen expression on CD 1a+ epidermal cells and a pronounced increase in the number ofHECA-452+ /COla+ dermal cells in lesional skin E pidermal Langerhans cells (LC) are major histocompatibility complex class I/class II-bearing dendritic leukocytes with potent antigen-specific T -cell-stimulating properties [1, 2] . Whereas LC were previously regarded as a rather sessile cell population, it is now clear that the fairly constant numbers of anti-CD la-reactive human LC result from a delicately balanced interplay of three factors: a) immigration, b) mitosis, and c) emigration. Although the occurrence of these truee events has been amply documented [3] , the mechanisms underlying these phenomena are only partly understood. In the very recent past, we have gained insight into the factors stimulating mitotic activity in putative LC precursors [4] as well as those triggering LC emigration § [5]; in contrast, the factors responsible for Manuscript
from inflammatory and neoplastic lymphocytic skin diseases, compared to normal skin. The molecule detected by the HECA-452 antibody on Langerhans cells is neuraminidase sensitive and contains a C015 (LewisX) carbohydrate backbone. Because Langerhans cells react with the sialylLewisx-specific antibody CSLEX1, it is very likely that the HECA-452-reactive structure is or contains sialyl-Lewis x . Our data are compatible with the view that i) resident epidermal Langerhans cells upregulate HECA-452 -antigen expression due to the cytokine profile generated in the disease process or ii) that Langerhans cell precursors express HECA-452-antigens and show an enhanced immigration into lesional skin. The characterization ofHECA-452+ cells in peripheral blood may not only clarify this issue but may also help to identify the still elusive Langerhans cell-precursor. Key words: sLeX, CD15. ] Invest DermatoI102: 773 -7BO, 1994 the immigration of LC/LC precursors into the skin have remained enigmatic.
The reason why one assumes that the homing ofLC to the skin/ epidermis occurs in a directed rather than random fashion is based on the observations i) that intravenously injected LC specifically ~ome to the skin (6) and ii) that certain T-Iymphocyte subpopulatlOns home preferentially to the skin [7, 8] . In this respect, particular attention has focused on molecules detected by the monoclonal antibody (MoAb) HECA-452. This MoAb reacts with more than 80% ofT cells infiltrating inflamed areas of the skin, but only with a low percentage (less than 10%) ofT cells at other sites of intlammation [8] . The T-cell structure detected by this MoAb has therefore been termed "cutaneous lymphocyte-associated antigen" (CLA) [9] . Biochemical studies have revealed that MoAb HECA-452 recognizes the carbohydrate structures i) sialyl-Lewis x (sLe X ), the sialylated form of Lewis X (LeX; CD15), ii) sLea, an isomeric form of sLe x , and iii) closely related carbohydrate moieties [10, 11] . Various studies indicate that these carbohydrates serve as ligands for E-selectin (previously called endothelial leukocyte adhesion molecule-l [ELAM-l]) [10 -13] ; this vascular adhesion molecule is constitutively expressed at low levels on endothelial cells of the dermal microvasculature and its expression is highly upregulated during inflammation [14] . These findings, together with other observations showing i) that E-selectin -transfected L cells bind to isolated CLA-antigen (11) and ii) that memory T cells expressing CLA-antigen bind to E-selectin-transfected COS cells [15] , led to the hy- pothesis that the interaction of E-selectin and CLA is crucial for T -cell homing to the skin.
R easoning that analogous mechanisms could also facilitate the homing of other leukocytes to the skin, we searched for the presence of HECA-452-reactive epitopes on epidermal LC in normal and diseased skin.
MATERIALS AND METHODS
Specimen Collection, Tissue, and Cell Preparation Four-millimeter punch biopsies of normal skin from the upper arm were taken from three healthy volunteers with normal-appearing skin and no history of any skin disease. Samples of lesional skin were obtained from patients suffering from various inflammatory and neoplastic lymphocytic skin diseases (see Table  II ). A small portion of each biopsy was processed for routine histopathology and the rest of the specimens were embedded in Tissue-Tec II OCT (Miles Laboratory Inc., Elkhart, IN) , frozen in 2-methylbutane (Merck, Darmstadt, Germany) cooled with liquid nitrogen, and stored at -80'C. Seven-micrometer cryostat sections were cut, mounted on poly-L-Iysine (Sigma Corp., St. Louis, MO) or gelatin-coated slides, airdried, fixed in acetone (Fluka, Buchs, Switzerland) on ice for 20 min, and stored at -20 'C until use.
To prepare i) epidermal sheets and ii) epidermal single-cell suspensions for flow cytometry, split-thickness skin (0.4 mm) was prepared from normalappearing skin obtained from patients undergoing cosmetic surgery or from autopsy specimens using an electric dermatome (DePuy Healthcare, Leeds, UK). After two to three washes in. ice-cold phos'phate-buff~red saline (PBS) , pH 7.4, the skin was exposed to dlspase (2.4 U/ml, Boehnnger Mannhelm, Mannheim, Germany) either at 4'C overnight or for 1 hat 37'C. Thereafter epidermal sheets were removed and either washed twice in PBS and fixed for 15 min in ice-cold acetone (Fluka) or incubated for 15 min at 37'C in 0.1 % (w Iv) trypsi n (Sigma)/PBS under mild agitation. The trypsin-treated sheets were then vigorously stirred for 45 seconds to release non-coherent cells. The resulting cell suspension was filtered through nylon gauze and washed in RPMI 1640 medium (Gibco, Paisley, UK) containing 10% fetal bovine serum (Gibco) and 0.25 mg/ml DNase I (EC 3.1.21.1, Sigma).
Immunohistologic Staining Primary and secondary antibodies used in this study are listed in Table l . Antibodies were diluted in staining-buffer containing 5% (w Iv) milk proteins, 0.1 % (v Iv) polyoxyethylene sorbitan mono laureate (TWEEN-20, Bio Rad, Richmond, CAl, and 2% (v/v) each normal sheep (Serotec Ltd., Kidlington, UK) and human AB serum (Immuno AG, Vienna, Austria). All sections were exposed to 10% sheep/2% human AB serum for 40 min at room temperature (RT) before staining. Slides were washed once in Tris-buffered saline, pH 7.6, and twice . ..in PBS between all incubation steps.
For single stainings, sections were incubated overnight at 4' C with unconjugated MoAb HECA-452, Leu-Ml, or IOT6, followed by either biotinylated sheep-anti-rat Ig antibody (Amersham) or biotinylated sheepanti-mouse Ig F(ab'), fragments (Amersham) for 1 hat RT. Detection of antibody binding was achi eved with peroxidase-conjugated StreptABComplex (Dako A/S, Glostrup, Denmark) and 3-amino-9-ethyl carbazole (Sigma) in acetate-buffer (PH 5.0) . Sections were counterstained with HARRIS' hematoxylin (Merck) and finally cover-slipped with a mixture of PBS/glycerol and Mowiol (Hoechst, Hoechst, Germany) . Double stainings were performed by incubating the cryostat sections overnight at 4'C in staining-buffer containing MoAb HECA-452. Antibody binding was detected by consecutive incubations with biotinylated sheep-anti-rat Ig antibody (Amersham) and Streptavidin Texas Red (SA-TR; Amersham), each for 1 hat RT. For counterstaining, sections were then overlaid with MoAb IOT6, the binding of which was visualized by consecutive incubations with fluorescein-isothiocyanate (FITC) -labeled rabbitanti-mouse Ig F(ab'), fragments (Dako) diluted in staining buffer (see above) containing 2% (v Iv) rat serum and FITC-labeled swine -anti-rabbit Ig antibody (Dako) diluted in staining-buffer containing 2% (v Iv) rat serum and 2% (v Iv) pig serum. Epidermal sheets were labeled with MoAb HECA-452/SA-TR as described above and counterstained with OKT6-FITC for 1 hat RT. After final washes in PBS, sheets were mounted dermal side up on glass slides and cover slipped with a mixture of PBS/glycerol and Mowiol (Hoechst) . In additional experiments, sections were incubated overnight at 4'C with anti-CD3 MoAb UCHTI (Dako) and antibody binding was detected by consecutive incubations with biotinylated sheep-anti-mouse Ig F(ab'),fragments (Amersham) and SA-TR, each for 1 hatRT. Sections were then counterstained with OKT6-FITC for another 1 hat RT.
Cross reactivity between antibodies or unspecific binding via Fc-receptors was excluded by using appropriate species/isorype-matched controls (see Table I ) . Stained sections and sheets were evaluated with a Nikon Epi-F3 (Nikon, Tokyo, Japan) or a Leitz Diaplan (Leitz, Wetzlar, Germany) epifluorescence microscope equipped with the appropriate excitation and emmission filters for FITC and Texas Red illumination. Staining patterns observed were documented with an automatic exposure system, using Ektachrome P800/ 1600 (Kodak, Rochester, UK) or ILFORD FP4 Plus (ILFORD Limited, Mobberley, UK) films .
Neuraminidase Digestion of Skin Sections Neuraminidase digestion of cryostat sections was performed for 30 min at 37'C using 40 mU/m1 neuraminidase of Vibrio clJOlerae (Behring, Marburg, Germany) in PBS containing 4 mM CaCl 2 and 1% (w/v) bovine serum albumin (Sigma). Mock digestion was performed in digestion buffer without neuraminidase. After washing in PBS, sections were subjected to HECA-452 or anti-CD 15 single stainings as described above. • Serial sections were stained with either HECA-452 or OKT6 MoAbs. The percentage of HECA-452+ LC was estimated by the comparison of the number of OKT6+ and HECA-452+ suprabasally located dendritic cells. Only data from specimens not evaluated by immunofluorescence double-label ing are included in this part of the table .
• CD30+ secondary large cell anaplastic lymphoma. HECA-452+ and COla+ cells were counted within the epidermis above the barely epidermotropic neoplastic infiltrate. , HECA-452+ and COla+ cells were counted in the lesional epidennis partly infiltrated by neoplastic T cells. J HECA-452+ and COla+ cells were counted within the epidermal cords of the lesion, as well as, in the perilesional epidermis. In both instances 4% of the COla+ cells coexpressed HECA-452-antigens.
, Results are means ± SO.
clase -anti-CD 1a -stained sections were used. The numbers of positive cells per linear millimeter basement membrane as well as per square millimeter were evaluated in the epidermis and the papillary dermis using a semi-automatic image analysis system (Vidas, Kontron Elektronik GmbH, Eching, Germany).
Flo-w-Cytometric Analysis of Epidermal Cells Epidermal cells were prepared for flow-cytometric analysis by washing in azide containing buffer (PBS/l % fetal bovine serum/O.l % sodiumazide/0.5 rnMethylene diaminetetraacetic acid) followed by incubation with normal sheep serum (5 %, v Iv) and further washes in azide containing buffer. 1 X 10 6 cells/lOO III were reacted with first-step antibodies (HECA-452, CSLEX 1, or control IgM) for 30 min on ice and washed once in azide containing buffer. Antibody-binding was visualized by incubation with either biotinylated sheep -anti-rat Ig antibody (Amersham) or biotinylated sheep-anti-mouse Ig F(ab'), fragments (Amersham) for 20 min on ice followed by Streptavidin Phycoerythrin (SA-PE; Becton Dickinson, San Jose, CAl. Cells were then counterstained for 20 min with either MoAb OKT6-FITC, HLe-l-FITC, or species/isorype-matched FITC-Iabeled control MoAb. After two washes fluorescence was measured in a FACScan (Becton Dickinson). Dead cells were identified by 7-amino-actinomycin D (7-AAD; Sigma) uptake and electronic gates were first set to acquire 10,000 living cells and then set to acquire only CD1a+ living cells.
RESULTS
HECA-452-reactive Cells in Normal Skin Exposure of cryostat sections of normal human skin to MoAb HECA-452 revealed the presence of stained cells scattered throughout the epidermis and dermis. Within the dermis, the majority of labeled cells were located in the vicinity of vessels, displayed a round shape, and, thus, presumably represent T lymphocytes [7, 8, 16] . As previously reported [16-18J, dermal endothelial cells were essentially non-reactive with MoAb HECA-452. Epidermal HECA-452+ cells consisted of i) a few round cells scattered throughout the basal layer (again probably representing T cells [8, 16] ) and ii) suprabasally located dendritic cells (data not shown). To see whether the latter cells are LC, we subjected cryostat sections and sheets of normal skin to an immunofluorescence double-labeling protocol using MoAb HECA-452 and anti-CDla MoAb IOT6. Results obtained revealed that 5 to 40% (20 ± 18%, mean ± SD; Table II) of CDla+ epidermal cells specifically bound MoAb HECA-452. Although the majority of these cells exhibited only a weak HECA-452 reactivity, a few brightly stained cells were also detected (Fig 1) . The intensity of the HECA-452 staining did not correlate with the level of CDla expression, because LC that stained weakly with anti-CDla MoAb sometimes expressed high levels of HECA-452-antigens and vice versa. As opposed to the results obtained on tissue preparations, we found that most, if not all, CDla+ cells reacted with the MoAb HECA-452 when single-cell suspensions of normal epidermis were stained and analyzed by flow cytometry (Fig 2) . To verify that the epidermal HECA-452+ /CD1a+ cells are LC and do not represent HECA-452+ /CDla+ T cells, we performed CDla/CD3 doublelabeling of cryostat sections. In keeping with the literature [1 ,19] , we never detected CDla+ cells expressing CD3-determinants (data not shown), indicating that the epidermal HECA-452+ /CDla+ cells indeed represent LC. Keratinocytes did not stain with MoAb HECA-452 on cryostat sections, on epidermal sheets, or in singlecell suspensions (Figs 1 and 2 ).
HECA-452-Reactive Cells in Diseased Skin In view of reports of increased numbers of HECA-452+ cells in inflamed skin [18] . we asked whether this increase could be, at least partially, due to an increase in the number of HECA-452+ LC. When we analyzed skin sections from various inflammatory and neoplastic lymphocytic skin disorders for HECA-452-antigen expression, we noted considerably larger numbers of HECA-452+ cells in both dermis and epidermis of diseased skin as compared to normal skin. Double-staining with anti-CDla MoAb revealed that i) approximately 50% of the HECA-452+ cells in the dermis belong to the LC-lineage and ii) that 50% to 80% of all CDla+ dermal cells exhibited a strong labeling with the MoAb HECA-452 (Fig 3) . The increase in absolute numbers of dermal HECA-452+ cells was therefore not only due to an elevation in HECA-452+ /CD la-cells (Fig 3) , which according to the literature are likely T cells [8, 16] and monocytic cells [16, 18] , but was also due to an increase in the absolute numbers of CDla+ dermal cells (Table III) . In contrast, the marked increase in HECA-452-reactive epidermal cells was not accompanied by elevated numbers of CD1a+ cells (Table III) , was not due to a substantial increase in HECA-452+ non-LC (except in MF, data not shown), but rather a consequence of enhanced HECA-452-antigen expression by CD1a+ dendritic cells (Fig 3) . Enumeration ofHECA-452+ /CDla+ and HECA-452-/CDla+ cells in the epidermis of the various inflammatory and neoplastic lymphocytic dermatoses studied revealed that 53-95% (71 ± 17%, mean ± SD) of the CDla+ cells expressed HECA-452 -reactive epitopes (Table  II , left columns). To confirm that the enhanced expression ofHECA-452-reactive moieties on CDla+ cells is representative of the examined disease entities, we subjected a larger panel of sections obtained from additional patients to HECA-452 single-labeling. Results obtained showed again that, compared to the situation in the skin of normal healthy volunteers, the lesional epidermis from patients with pseudolymphoma, atopic and contact eczema, psoriasis, ... (Fig 4) . Second, skin sections were treated with neuraminidase or control buffer and then either stained with MoAb HECA-452 or anti-CD15. Whereas epidermal cells in the mock-digested samples reacted with MoAb HECA-452, but not with anti-CD15 MoAb Leu-M1, neuraminidase digestion of the sections led to the loss of HECA-452 reactivity and to the gain of anti-C?15 reactivity (Fig 5) . These data. show that the epitope recogmzed by the MoAb HECA-452 on epidermal LC and T cells is a sialylated form of LeX. In concordance with the absence of HECA-452-reactivity on keratinocytes, we could not detect binding of MoAb CSLEX1 on this epidermal cell population (Fig  4) , and keratinocytes in the neuraminidase digested sample did not label with MoAb Leu-M1 (Fig 5) .
DISCUSSION
The rat MoAb HECA-452 has been described to recognize carbohydrate moieties on skin-prone memory T cells [7] . We have now detected similar antigens on human epidermal LC. Immunolabeling of cyrostat sections and epidermal sheets of normal skin re- At first glance, the detection ofHECA-452-reactive epitopes on LC may be surprising because Bos et af [16] recently reported HECA-452 MoAb binding to T-cell and macrophage subpopulations of normal skin, but absence ofHECA-452 immunolabeling of epidermal CDla+ cells. In addition, Jalkanen et af [18] reported enhanced numbers of HECA-452+ and CD1a+ dendritic cells in diseased versus normal skin, but stated that the populations recognized by MoAbs HECA-452 and anti-CDla were not identical. We would presume that the sensitivity of the staining system used may account for the discrepancies between these observations and our finding. In this context, it should be emphasized that i) the HECA-452 labeling we detected on approximately 20% of CD1a+ cells in cryostat sections of normal skin was generally rather dull and ii) that uniform HECA-452 labeling of LC was only revealed by flowcytometric analysis of epidermal single cell suspensions. In principle this difference could be due to i) the higher sensitivity of flow-cyto- • With the exception of contact eczema and parapsoriasis, data were obtained from sections cut from the same biopsies as used for the determination of the percentage of HECA-452+ LC (Table II) . In the case of contact eczema and parapsoriasis two and three biopsies, respectively, were obtained from patients other than those used in T able U.
b CD30+ secondary large cell anaplastic lymphoma.
, Results are means ± SD. metric analysis compared to fluorescence microscopy, ii) an unmasking of the reactive epitope by the enzyme treatment used to prepare the single cell suspension, and/or iii) an upregulation of this antigen during cell preparation~ [20] . However, because treatment of cryostat sections from normal skin with trypsin prior to staining did not lead to enhanced reactivity of MoAb HECA-452 with LC and because there was no significant variation in HECA-452 reactivity on LC in epidermal sheets prepared with either trypsin, dispase, or NH 4 SCN (data not shown), unmasking of HECA-452-reactive epitopes by trypsin does not seem to be the reason for the detection of higher percentages of HECA-452+ cells upon flow cytometry compared to in sil/j immunohistochemistry. This conclusion is further supported by the observation that an epidermal single cell suspension prepared with dispase and ethylene diaminetetraacetic acid showed a similar staining pattern as the trypsintreated sample of the same specimen (data not shown). The third possibility, namely, upregulation of the HECA-452 antigen during cell preparation. also seems to be a rather unlikely explanation. because ex villo culture of whole skin specimens up to 72 h did not result in increased HECA-452 binding to LC (data not shown). Due to theoretical considerations (such as the higher amount of antigen present on single cells compared to sectioned cells and the higher sensitivity of photomultipliers in the flow cytometer compared to the investigators eyes examining tissue specimens by fluorescence microscopy), we believe that the main reason for the discrepancy between the in sitll and the flow-cytometry results is the different sensitivity of the two readout systems used. The structure recognized by the MoAb HECA-452 has been reported to be serologically identical to sLe x on neutrophils [11] but to differ from sLe X on established memory/effector T cells [7, 10, 11] . Although the molecular configuration detected by HECA-452 on monocytes [8] , dendritic cells [21] , and high endothelial venules [17, 22] has not been studied in detail. it seems to involve sLe x beca,use these cells react with the sLex-specific MoAb CSLEX1 [23 -26] . To define the molecular configuration of the HECA-452-reactive epitope on LC we performed two series of experiments. First, double-labeling of epidermal single cell suspensions with CSLEX1 and anti-COla MoAbs revealed that all LC express sLe x . This result confirms a recent publication showing that C01a+ cells of buccal muCOsa and normal skin label with the anti-sLeX MoAb FH6 [27] . In further experiments, we found that treatment of skin sections with neuraminidase leads to the loss of HECA-452 binding and to the unmasking of C01S (LeX) [19] . similar to what has been reported for T cells [11 J. These experiments show that binding ofHECA-452 is dependent on the expression of LeX carbohydrates decorated with sialic acid. Although these data strongly suggest that the HECA-452-reactive structure on LC is sLe x , the expression of other HECA-452 -reactive oligosaccharides cannot be excluded. In addition to HECA-452 recognizing different carbohydrate molecules on different cells. the protein backbone to which the carbohydrates are attached also differs between various leukocyte subsets [8] . Proteinbiochemical studies would be needed to fully characterize the HECA-452 -reactive antigens on LC.
Although Symington et al [28] recently reported that trypsintreated keratinocytes react with an anti-sLe x MoAb, we could not detect binding of either HECA-452 or CSLEX1 to trypsin-treated keratinocytes. Because Symington et al [28] used different MoAbs, one explanation for the contradictory result might be that the MoAbs employed by us do not bind to keratinocytes because of lower affinity and/or steric hindrance.
How is the expression of the HECA-452-reactive molecule on LC regulated? It is known that T cells acquire CLA expression during the naive to memory cell transition in skin-associated peripherallymph nodes [7] and that CLA expression can be induced in vitro by mitogen stimulation ofT cells in combination with interleukin-6 or transforming growth factor-fJ [7] . In analogy one might presume that the HECA-452 -reactive structure on LC may also be induced by the presence of antigen and cytokines. Compatible with this assumption are our data that LC residing in the epidermis of lesional skin from inflammatory or neoplastic lymphocytic disorders show a markedly enhanced expression ofHECA-452-reactive molecules. Both the percentage of LC expressing detectable levels of HECA-452-reactive molecules (71 ± 17% versus 20 ± 18%, P < 0.001) and the intensity of staining with this MoAb on a single celllevcl were increased in diseased versus normal skin. In contrast, in seborrheic keratosis. a hyperproliferative disorder of keratinocytes not accompanied by T-cell infiltration, only small numbers of HECA-452+ LC were seen. Thus, it is possible that cytokines released from the infiltrating/neoplastic T cells may induce the expression of HECA-452-reactive antigens on resident epidermal LC. On the other hand, it is equally conceivable that LC precursors enter the skin in a HECA-452+ state. Once establishing residence in the epidermis, the cytokine level they encounter determines the degree to which HECA-452-antigen expression is maintained.
CONCLUSION
At the moment, it is unclear which, if either, of these concepts is valid. The assumption that the functional significance of HECA-452 -antigen expression by a given cell is to allow its binding to E-selectin provides us with a logical argument favoring the latter hypothesis. First, there is no evidence for a role of HECA-452-antigen expression on resident LC, especially as keratinocytes do not express E-selectin [14, 29] and adhesion of LC to keratinocytes has been shown to be mediated via E-cadherins [30] . Second, the possibility that resident LC upregulate HECA-452-antigen expression when they leave the epidermis to gain access to the lymphatics [31] is unlikely, because i) we have not seen E-selectin expression on vascular structures consistent with lymphatics (L. Picker, unpublished observation) and ii) we are not aware of data indicating that receptor-ligand interactions playa role in lymphocyte recruitment into lymphatic vesse ls. Conversely, there is circumstantial evidence supporting the hypothesis that LC precursors express HECA-452 antigens, which might enable these precursors to bind to the dermal microvasculature and, thus, faci litate their extravasation into the skin. Our observation of markedly enhanced numbers of HECA-452+ /CD1a+ cells in the dermis of most dermatoses studied may be taken as an indication of an increased immigration of LC-precursors into lesional skin. The upregulation of Eselectin expression by the dermal microvasculature in inflammatory skin [14] and in neoplastic lymphocytic disorders [32] may provide the necessary basis for this process. After LC (precursors) reach the epidermis and take residence between the keratinocytes their HECA-452-antigen expression would then gradually decrease either due to a lack of appropriate stimuli or due to active downregulation. This might explain our finding that in normal skin, where recruitment of LC would be expected to be at relatively low levels, most LC are HECA-452-/dull. The observation that developing monocytes upregulate HECA-452 reactivity in the bone marrow, maintain high levels in the blood, and rapidly lose expression of these determinants during differentiation into tissue macrophages (both il1l1ilro and ill lIillO, L. Picker, unpublished), is in keeping with this concept. The identification of cells in the peripheral blood that react with HECA-452 or CSLEX1 and do not express either T-cell or neutrophil markers may verify this hypothesis and perhaps even lead to the discovery of the still elusive LC-precursor. 
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